Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis

M. Cutolo, A. Sulli, P. Ghiorzo, C. Pizzorni, C. Craviotto, B. Villaggio

Research output: Contribution to journalArticlepeer-review


Background: Leflunomide and its active metabolite A77 1726 reversibly inhibits the enzyme dihydroorotate dehydrogenase, the rate limiting step in de novo synthesis of pyrimidines and progression of the cell cycle in different cell lines, mainly activated T lymphocytes. Objective: To analyse in vitro the possible anti-inflammatory effects exerted by A77 1726, on cultured macrophages, obtained from the synovial tissues of patients with rheumatoid arthritis (RA). Methods: The effects of different doses of A77 1726 on intracytoplasmic expression and extracellular concentration of inflammatory cytokines (tumour necrosis factor α (TNFα), interleukin (IL) 1β, IL6), as well as the influence on production and expression of intercellular adhesion molecule-1 (ICAM-1) and cyclo-oxygenase 2 (COX-2) by primary cultures of synovial macrophages from patients with RA, were evaluated by immunocytochemistry and western blot analysis. The observations were made at four and 24 hours. Results: A progressive and significant time and dose dependent decrease of the number of positive macrophages for intracellular TNFα and IL 1β, treated with different doses of A77 1726, was found in comparison with untreated cells. The extracellular concentration of TNFα was found to be significantly decreased in media containing cultured macrophages at 24 hours for all tested doses of A77 1726. At 24 hours, a significant time and dose dependent decrease of ICAM-1 and COX-2 expression by cultured macrophages after A77 1726 treatment was found. Conclusions: In conclusion, the mechanism of antiproliferative activity exerted by leflunomide on activated T lymphocytes seems to be the same mechanism (alteration of the cell cycle progression) which interferes with the functions of other activated cells - namely, the monocytes/macrophages, which are strongly involved in the inflammatory reaction in RA synovial tissue. The positive clinical results seem to confirm that leflunomide exerts an anti-inflammatory action on phagocytic cells in short and long term treatment of RA.

Original languageEnglish
Pages (from-to)297-302
Number of pages6
JournalAnnals of the Rheumatic Diseases
Issue number4
Publication statusPublished - Apr 1 2003

ASJC Scopus subject areas

  • Rheumatology
  • Immunology


Dive into the research topics of 'Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this